Table 1.
Sample characteristics
| M (SD) | N (%) | |
|---|---|---|
| Age (N = 42) | 65.88 (13.01) | |
| Sex (N = 42) | ||
| Female | 29 (69.0) | |
| Male | 13 (31.0) | |
| KPSS (N = 42, Range: 0–100) | 40.55 (14.97) | |
| gQOL (N = 40, Range: 0–10) | 4.75 (2.45) | |
| Diagnosis (N = 42) | ||
| Gynecological cancer | 11 (26.2) | |
| Pancreatic cancer | 6 (14.3) | |
| Gastrointestinal cancer | 5 (11.9) | |
| Thoracic cancer | 3 (7.1) | |
| Prostate cancer | 2 (4.8) | |
| Other cancer | 13 (31.0) | |
| Non-oncological disease | 2 (4.8) | |
| Medication (N = 80) | ||
| Analgesic = YES | 72 (90.0) | |
| Antidepressant = YES | 15 (18.8) | |
| Antipsychotic = YES | 14 (17.5) | |
| Cardiovascular = YES | 53 (66.3) | |
| Corticosteroid = YES | 72 (90.0) | |
| Hormonal = YES | 14 (17.5) | |
| Sedative = YES | 13 (16.3) | |
| Xerostomia (N = 80) | 56 (71.8) | |
| Mouth injuries (N = 80) | 9 (11.5) | |
Notes: M mean, SD standard deviation, KPSS Karnofsky Performance Status Scale, gQOL global quality of life (McGill Quality of Life Questionnaire – Revised)